Physician profile
Priya Verghese
NPI 1902917891
$16,850.76
in general payments reported to CMS, 2019-2025
10 companies · $15K in 2025
The $15K reported for 2025 was more than what 94% of Pediatric Nephrology providers received nationally (typical 2025 total: $131).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $117 · 2022: $114 · 2023: $1,887 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Travel and Lodging: $1,696 · Food and Beverage: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,109.70 |
| Travel and Lodging | $1,696.39 |
| Food and Beverage | $813.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $14,189.45 | 2023-2025 | |
| Ns Pharma, INC. | $1,859.70 | 2023 | Viltepso |
| Boehringer Ingelheim International Gmbh | $353.02 | 2025 | |
| Alexion Pharmaceuticals, INC. | $219.11 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $114.30 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.26 | 2025 | |
| Nuwellis, INC. | $29.92 | 2025 | Aquadex Smartflow Console |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priya Verghese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.